SCHEMBL20983862

SCHEMBL20983862

O=C(OC(C(F)(F)F)C(F)(F)F)N1CCc2cc(Br)ccc21

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ABHD6 Q9BV23 14/20 1.00
▸ TUBB4A P04350 1/20 0.48
▸ TUBB P07437 1/20 0.48
▸ TUBA3C P0DPH7 1/20 0.48
▸ TUBA1B P68363 1/20 0.48
▸ TUBA4A P68366 1/20 0.48
▸ TUBB4B P68371 1/20 0.48
▸ TUBB3 Q13509 1/20 0.48
▸ TUBB2A Q13885 1/20 0.48
▸ TUBB8 Q3ZCM7 1/20 0.48
▸ TUBA3E Q6PEY2 1/20 0.48
▸ TUBA1A Q71U36 1/20 0.48
▸ TUBA1C Q9BQE3 1/20 0.48
▸ TUBB6 Q9BUF5 1/20 0.48
▸ TUBB2B Q9BVA1 1/20 0.48
▸ TUBB1 Q9H4B7 1/20 0.48
▸ SLC22A12 Q96S37 1/20 0.48
▸ PLA2G7 Q13093 1/20 0.47
▸ MGLL Q99685 1/20 0.47
▸ NOTUM Q6P988 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20983847 0.79 ABHD6 (1.00) ABHD6MGLL
SCHEMBL20983737 0.79 ABHD6 (1.00) ABHD6MGLL
SCHEMBL8440098 0.79 ABHD6 (0.65) ABHD6TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL2083808 0.78 ABHD6 (0.64) ABHD6TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL18921803 0.78 ABHD6 (0.64) ABHD6TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL760643 0.77 ABHD6 (0.63) ABHD6TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL31014045 0.77 ABHD6 (0.63) ABHD6TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL20983795 0.75 ABHD6 (1.00) ABHD6MGLL
SCHEMBL2373819 0.74 ABHD6 (0.59) ABHD6TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL288802 0.74 SLC22A12 (0.59) ABHD6TUBB4ATUBBTUBA3CTUBA1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190152917-A1 ABHD6 AND DUAL ABHD6/MGL INHIBITORS AND THEIR USES MAKSCIENTIFIC, LLC 2019-05-23 — — US claimed
US-10662159-B2 ABHD6 and dual ABHD6/MGL inhibitors and their uses MAKSCIENTIFIC, LLC (US) 2020-05-26 — — US disclosed
US-20190152917-A1 ABHD6 AND DUAL ABHD6/MGL INHIBITORS AND THEIR USES MAKSCIENTIFIC, LLC 2019-05-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10662159-B2 ABHD6 and dual ABHD6/MGL inhibitors and their uses ABHD6, FAAH, FAAH2 ABHD6 1/4885TUBB4A 3880/4885TUBB 3267/4885
US-20190152917-A1 ABHD6 AND DUAL ABHD6/MGL INHIBITORS AND THEIR USES ABHD6, FAAH, FAAH2 ABHD6 1/4885TUBB4A 3880/4885TUBB 3267/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback